Surprise findings on NOAC adherence

One in three patients prescribed a NOAC become non-adherent within six months and are at greater risk of stroke, Canadian researchers have found.

Their research shows much higher non-adherence in the real world than in the original NOAC trials, which may “limit the expected benefits” of the drugs over warfarin.